Literature DB >> 10560502

Lung carcinoids. Tumor angiogenesis in relation to clinicopathologic characteristics.

J Slodkowska1, J Sikora, W Androsiuk, P Rudziński, A Radomyski.   

Abstract

OBJECTIVE: To evaluate the prognostic value of carcinoid angiogenesis for the presence of lymph node metastases, histologic subtype and tumor size. STUDY
DESIGN: The study group consisted of 72 resected primary lung carcinoids, 57 typical and 15 atypical. TNM staging was performed. The histologic criteria for carcinoids was based on the Flieder classification. Angiogenesis, expressed as tumor microvessel density, was estimated in sections stained with CD34 antibody, according to Weidner's method.
RESULTS: The size of carcinoids was related to the histologic type: the average tumor diameter of typical carcinoids was significantly smaller than the average diameter of atypical carcinoids (P = .003, U = 207, Z = -3.023). Atypical carcinoids represented a more aggressive form of tumors than typical carcinoids; patients with typical carcinoids developed lymph node metastases less frequently (10% vs. 33%) as compared to patients with atypical carcinoids; the difference was statistically significant (P = .032). Tumor angiogenesis failed to distinguish the histologic type of carcinoids and did not indicate the presence or absence of regional lymph node metastases; neither did pTN stage or tumor size.
CONCLUSION: Angiogenesis is not a determining factor of the metastatic potential of pulmonary carcinoids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560502

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  1 in total

1.  Modeling Lung Carcinoids with Zebrafish Tumor Xenograft.

Authors:  Silvia Carra; Germano Gaudenzi; Alessandra Dicitore; Maria Celeste Cantone; Alice Plebani; Davide Saronni; Silvia Zappavigna; Michele Caraglia; Alessia Candeo; Andrea Bassi; Luca Persani; Giovanni Vitale
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.